Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
USA – Eli Lilly has pushed back the deadline for submitting an application for U.S. approval of its experimental Alzheimer’s disease drug, revealing that it will now complete the filing…
Read More
USA – The FDA has placed a clinical hold on Denali Therapeutics’ Alzheimer’s drug before it even enters human trials. The decision has an impact on Takeda, which only recently…
Read More
USA – U.S. Health Secretary Xavier Becerra has directed the Centers for Medicare & Medicaid Services (CMS) to reconsider a hefty 2022 Medicare Part B premium hike proposal based in…
Read More
USA – Biogen is planning to lay off over 1000 employees following the disappointing launch of its Alzheimer’s therapy Aduhelm (aducanumab), according to STAT News. According to STAT News, Biogen…
Read More
USA – Clinical trial for Alzheimer’s disease (AD) nasal vaccine has been launched to see whether a potential treatment could be safe for humans after the therapy showed positive results…
Read More
EUROPE – European Medicines Agency (EMA) panel voted against approval of Biogen Inc’s Alzheimer’s drug Aduhelm, dealing another setback to the treatment already grappling with a slow rollout in the…
Read More
USA – The federal government has announced a significant increase in Medicare premiums, blaming the pandemic but also citing “uncertainty” about how much it may be forced to pay for…
Read More
WORLD – Biogen and Eisai have presented a design of the first real-world observational phase 4 study in Alzheimer’s disease by the name ICARE AD-US. ICARE AD-US, a prospective study…
Read More
US – Aduhelm was the first of its kind drug for Alzheimer’s disease to be approved in two decades under the accelerated approval by Food & Drug Association (FDA), however,…
Read More